$600.50
arrow_drop_up4.13%Key Stats | |
---|---|
Open | $582.71 |
Prev. Close | $577.00 |
EPS | 15.41 |
Next Earnings Date | Dec 24, 2024 |
LOW | HIGH | |
---|---|---|
Day Range | 582.56 | 602.59 |
52 Week Range | 436.38 | 630.25 |
Ratios | |
---|---|
EPS | 15.41 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
U.S. Primary Care Physicians Market Report 2024-2028: Trends and Challenges Shaping the Market, with Insights by Age Group, Type of Physician and Service
These Are the Top Health Stocks to Own for Buy-And-Hold Investing
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
UnitedHealth Group Pulls Back Into a Healthy Buying Opportunity
Prediction: These Could Be the Best-Performing Value Stocks Through 2030